Illumina, which specializes in DNA sequencing, will work on samples representing 1,300 species in the San Diego Zoo Wildlife ...

Illumina, Inc. (NASDAQ: ILMN) today announced a sequencing agreement with the San Diego Zoo Wildlife Alliance (SDZWA)'s ...

Illumina, Inc. (NASDAQ:ILMN) Q4 2025 Earnings Call Transcript February 5, 2026 Illumina, Inc. beats earnings expectations. Reported EPS is $1.35, expectations were $1.26. Operator: Good day, ladies ...

Illumina Inc (ILMN) reports a 5% revenue increase and a 42% rise in non-GAAP EPS, while navigating uncertainties in research funding and expanding its multiomics portfolio.

Genomics company Illumina (NASDAQ:ILMN) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 5% year on year ...

San Diego’s Illumina is the world leader in gene sequencing technology — the ability to read and record DNA. Now, the billion-dollar company is buying another in a bid to expand its portfolio in ...

The Illumina NovaSeq X adds to Agilus Diagnostics’ molecular testing portfolio through high-throughput sequencing and ...

Devyser today announced that it entered a strategic agreement with Illumina, a global leader in DNA sequencing and array-based technologies, to provide Illumina sequencing instruments and related prod ...

Total company revenue is projected at “$4.5 billion to $4.6 billion, representing reported growth of 4% to 6%,” with operating margins expected at 23.3% to 23.5% in 2026. EPS guidance is “$5.05 to ...

Investing.com -- Illumina Inc. (NASDAQ:ILMN) reported fourth-quarter earnings that beat analyst expectations, but shares plunged 8.7% in after-hours trading Thursday as the company’s flat annual ...

Illumina, Inc. (NASDAQ: ILMN) today announced that it has completed its acquisition of SomaLogic, a leader in data-driven ...

PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the ...